date:May 21, 2012
The study published in The Lancet challenges the assumption that raising levels of good high-density lipoprotein (HDL) cholesterol will necessarily lower the risk of heart disease.
It's been assumed that if a patient, or group of patients, did something to cause their HDL levels to go up, then you can safely assume that their risk of heart attack will go down, said senior author Sekar Kathiresan, an associate professor of medicine at Harvard Medical School. This work fundamentally questions